|
Market Closed -
Euronext Paris
19:55:00 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.670 EUR | -2.47% |
|
+3.21% | +64.67% |
| 09-29 | Genfit S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 486M | - | ||||
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
- Stock Market
- Stocks
- GNFT Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
